FIP/SIG Workshop: Special dosage forms – What’s new with in vitro drug release?

Monday 20 October

Keynote Presentations         
13:00 – 13:10  Introduction and Welcome   Vinod P. Shah, FIP, BPS, USA 
13:10 – 13:50  Current views of European Pharmacopeia on the Drug Release of Special Dosage Forms Susanne Keitel, EDQM, Germany 
13:50 – 14:30   Overview of USP Dosage Form Taxonomy Todd Cecil, USP, USA 
14:30 – 15:10   Overview of Current FIP SDF White Paper Jennifer Dressman, University of Frankfurt, Germany
15:10 – 15:30  Coffee Break 

Session 1: Specialized Oral Dosage Forms
Moderators: Jennifer Dressman, University of Frankfurt, Germany and Cynthia Brown, Eli Lilly & Compnay, USA
15:30 – 16:10 Orally Disintegrating Tablets – Disintegration vs Dissolution Lucinda Buhse, FDA, USA 
16:10 – 16:50 Buccal Dosage Forms Munir Hussain, Bristol Meyer Squibb, USA 
16:50 – 17:30 Chewable Oral Drug ProductsJ ohannes Kraemer, PHAST, Germany
17:30 – 18:00  Panel Discussion 

Tuesday 21 October
Session 2:  Non-Oral Dosage Forms
Moderators: Johannes Kraemer, PHAST, Germany and Mary Stickelmeyer, Eli Lilly & Company, USA 
08:00 – 08:10 Welcome – Session Overview 
08:10 – 08:50 Topical Clarence Ueda, University of Nebraska, USA 
08:50 - 09:30  Opthalmics Larry Stevens, Alcon Research, USA
09:30 -10:00  Break 
10:00 – 10:40 Drug-eluting Stents - Industry Perspective Lori Allgeuier, Cordis, USA     
10:40 – 11:20 Drug-eluting Stents  - Regulatory Perspective Angelica Durantes, FDA , USA
11:20 – 12:00  Panel Discussion
12:00 – 13:00  Lunch 

Session 3: Special Dosage Forms
Moderators: Mike Morris, Irish Medicines Board, Ireland and Todd Cecil, United States Pharmacopeia, USA 
13:00 – 13:40 Microspheres Siddhesh Patil, Amylin, USA 
13:40 – 14:20 Nanoparticles Roy De Maesshlack, Johnson & Johnson, Belgium
14:20 – 15:00 Liposomes Dr Hiroshi Kikuchi, Eisai Co.,Japan 
15:00 – 15:30 Break  
15:30 – 16:10 Is It Time for In Vitro Release Testing of Inhalation Dosage Forms? Neal Davies, University of Washington, USA 
16:10 – 16:40 In vitro release of suppositories TBC
16:40 – 17:20 Panel Discussion 
17:20 – 17:30 Conclusions and next steps
 

12.15